Lewis Bender

Chief Executive Officer at INTENSITY THERAPEUTICS, INC.

Net worth: 520 430 $ as of 31/05/2026

67 year

37 connections

Health Technology

Consumer Services

Finance

Profile

Lewis H.
Bender is the founder of Intensity Therapeutics, Inc., founded in 2012, where the titles held include Chairman, President & Chief Executive Officer.
Former jobs include Chief Executive Officer & Director at Interleukin Genetics, Inc. from 2011 to 2012, and President, CEO & Chief Technology Officer at Emisphere Technologies, Inc. from 1993 to 2007.
Education history includes graduate studies at the University of Pennsylvania, undergraduate and graduate degrees from the Massachusetts Institute of Technology, and an MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
INTENSITY THERAPEUTICS, INC. 4.39%	15/04/2026	1,18,549 ( 4.39% )	520 430 $	31/05/2026

Lewis Bender active positions

Companies	Position	Start
INTENSITY THERAPEUTICS, INC.	Chief Executive Officer	01/04/2012

All active positions of Lewis Bender

Former positions of Lewis Bender

Companies	Position	End
INTERLEUKIN GENETICS, INC	Chief Executive Officer	23/08/2012
EMISPHERE TECHNOLOGIES, INC.	Chief Executive Officer	01/12/2007

See the detail of Lewis Bender's experience

Training of Lewis Bender

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lewis Bender's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Emisphere Technologies, Inc. Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company	Health Technology
Interleukin Genetics, Inc. Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops personalized health products	Health Technology
Intensity Therapeutics, Inc. Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services